Digital Therapeutics R&D

A leading DTx co-dev partner

We offer end-to-end DM & DTx co-dev partnerships

We are an entrepreneurial and multi-disciplinary team of digital health experts, behavioral designers, clinical researchers, software engineers, and data scientists with a track record of successful co-development partnerships with pharmas and startups.
Putting patient needs at the core of all our products, our methodology defines DTx and Digital Medicines products through a rigorous scientific analysis, commercial sustainability potential and strategic market fit.
All of our solutions are created exclusively in-house by our technical team, and proof of concepts and MVPs development is accelerated thanks to our proprietary DTx platform (H.Core).
Our capabilities and innovation offerings are augmented by an evolving “partner-ready” DTx solutions pipeline with some of our products having already reached full clinical validation.
We also maintain an evergreen Digital Health innovation offering, seeking out novel solutions in all therapeutic areas via our Healthware Ventures arm, and by investing in the acceleration of promising new startups.


10/01/2022 | BlogPost

Digital health: making medicine more human

Healthcare companies have a unique opportunity to continue this momentum beyond the pandemic bubble as our CEO Roberto Ascione tells Dr Paul Tunnah at the 2021 Frontiers Health conference in Milan.

3/01/2022 | BlogPost

Gartner's 2022 technology trends predictions and how they reflect to healthcare industry

Gartner just recently introduced their top strategic technology trends for 2022. They are split into three categories: Engineering trust, Sculpting change and Accelerating growth. How do these reflect the healthcare and pharmaceutical industries?